Kind Lending partners with CANDID to modernize its mortgage operations, eliminate tech debt, and build a unified platform ...
Candid Therapeutics is continuing its mission to flesh out a pipeline of T-cell engagers in record time, signing a $925 million biobucks deal with WuXi Biologics for a preclinical candidate. The asset ...
Candid Therapeutics, a new San Diego biotech bent on becoming a leader in the emerging T-cell engager space, has unwrapped three new research collaborations focusing on autoimmune diseases. The EpimAb ...
As of March 2022, this review is no longer being updated. It covers an older business model of Candid and some features mentioned may no longer be available. Candid is an online company that sends you ...
As of the end of 2023, Candid ceased all direct-to-consumer clear aligner products and services, and is no longer associated with this profile. In the two years following the announcement, Candid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback